References
- Andreone P., Gramenzi A., Lorenzini S., Biselli M., Cursaro C., Pileri S., et al. Posttransplantation lymphoproliferative disorders. Arch Int Med 2003; 163: 1997–2004
- Kamel O. W., Rijn M., Weiss L. M., Zoppo G. D., Hench P. K., Robbins B. A., et al. Reversible lymphomas associated with Epstein–Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993; 328: 1317–21
- Salloum E., Cooper D. L., Howe G., Lacy J., Tallini G., Crouch J., et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996; 14: 1943–9
- Chevrel G., Berger F., Miossec P., Blanc M., Jeanneret J., Felman C., et al. Hodgkin's disease and B cell lymphoproliferation in rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1999; 42: 1773–6
- Moseley A. C., Lindsley H. B., Skikne B. S., Tawfik O. Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease. J Rheumatol 2000; 27: 810–13
- Dawson T. M., Starkebaum G., Wood B. L., Willkens R. F., Gown A. M. Epstein–Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren syndrome. J Rheumatol 2001; 28: 47–53
- Kelaidi C., Tulliez M., Lecoq‐Lafon C., Kahan A., Dreyfus F., Bouscary D. Long‐term remission of an EBV‐positive B cell lymphoproliferative disorder associated with rheumatoid arthritis under methotrexate with anti‐CD20 monoclonal antibody (Rituximab) monotherapy. Leukemia 2002; 16: 2173–4
- Starkebaum G. Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein–Barr virus?. J Rheumatol 2001; 28: 2573–5